Last edition
News about "Fabrizio Mazzocchi, CEO of Copan Diagnostics "
Copan Diagnostics Invests USD 7 Million to Expand US Manufacturing Footprint
Copan Diagnostics, part of the privately held Italy-based Copan Group, has announced more than USD 7 million in new US manufacturing investments across its facilities in California and Puerto Rico.
Fabrizio Mazzocchi, CEO Of Copan Diagnostics | 25/09/2025 | By Dineshwori | 217
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members